Monsenso A/S (CPH:MONSO)

Market Cap	14.25M
Revenue (ttm)	10.80M
Net Income (ttm)	-6.61M
Shares Out	74.60M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,702
Average Volume	22,131
Open	0.1920
Previous Close	0.1920
Day's Range	0.1910 - 0.1920
52-Week Range	0.1000 - 0.4700
Beta	1.22
RSI	57.51
Earnings Date	Mar 5, 2026

About Monsenso

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution, a software as a medical device for mental health professionals application that has data collection, direct messaging, visualization and feedback, psy...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 13
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: MONSO

Financial Performance

In 2024, Monsenso's revenue was 11.17 million, an increase of 16.01% compared to the previous year's 9.62 million. Losses were -6.00 million, 12.0% more than in 2023.